Isoniazid (generic), Nydrazid, Laniazid News

Tuberculosis contributes significantly to morbidity and mortality among HIV-infected children in sub-Saharan Africa.

While extreme nonadherence is readily apparent, it is rare compared to lesser degrees of nonadherence, which are difficult to predict.

International guidelines for treating tuberculosis need to be updated to recommend six months of rifampicin treatment in first-line therapy for all countries, and to improve the ways in which relapsers and isoniazid-resistant patients are treated, according to two systematic reviews published this week in the open access journal PLoS Medicine .

Every year nearly ten million people develop tuberculosis , a contagious infection, usually of the lungs.

Objective To develop an animal model of intraocular tuberculosis with features of pulmonary TB and extrapulmonary dissemination to the eye.

International guidelines for treating tuberculosis are due for specific improvements, according to two research papers published this week in the open access journal PLoS Medicine .

Picture of the Month - Diagnosis Arch Pediatr Adolesc Med. 2009;163 :864. Denouement and Discussion: Chronic Cutaneous Ulcer Cranial and vertebral magnetic resonance imaging revealed destruction of the second thoracic vertebra and a major paravertebral abscess, causing cord compression, which suggests tuberculous spondylitis.

Drug-resistant tuberculosis is considered a real threat to the achievement of TB control.

Tuberculosis is one of the world's oldest diseases. It is curable, but in some parts of the world, you would never know it.

NEW Abstract Isoniazid is an essential drug used to treat tuberculosis. The mycobactericidal agents are INH adducts [INH-NAD ] of the pyridine nucleotide coenzymes, which are generated in vivo after INH activation and which bind to, and inhibit, essential enzymes.

NEW Abstract Isoniazid is an essential drug used to treat tuberculosis. The mycobactericidal agents are INH adducts [INH-NAD ] of the pyridine nucleotide coenzymes, which are generated in vivo after INH activation and which bind to, and inhibit, essential enzymes.

South Africa is surging ahead in the fight against TB but drug-resistant strains still pose a huge threat, according to new research at the International Aids Society conference in Cape Town this week.

MDR-TB is particularly dangerous because it can give rise to extensively drug-resistant M. tuberculosis , which requires aggressive treatment using a combination of five different drugs.

Relapse Associated with Active Disease Caused by Beijing Strain of Mycobacterium tuberculosis 1 William J. Burman, Erin E. Bliven, Lauren Cowan, Lorna Bozeman, Payam Nahid, Lois Diem, and Andrew Vernon, for the Tuberculosis Trials Consortium Author affiliations: Denver Public Health, Denver Colorado, USA ; University of Colorado at Denver Health ...

The journal Lancet Infectious Diseases examines the worldwide spread of extensively drug-resistant tuberculosis .

This "revolutionary" test will shorten the 2 to 4 months it now takes to detect multidrug-resistant TB down to mere hours, according to Mario Raviglione, MD, director, WHO tuberculosis program.

Promising Interim Results of a Study of TMC207, a New Experimental Drug for Treatment of Multidrug-resistant Tuberculosis By Ronald Baker, PhD Tuberculosis bacillus The June 4, 2009 issue of the New England Journal of Medicine features an article on the new experimental drug TMC207 for the treatment of multi-drug resistant tuberculosis .

The first new tuberculosis drug in 40 years has been shown to make current treatment 5 times more effective against drug-resistant TB, Reuters reported Wednesday.

Case 18-2009 - A 24-Year-Old Woman with AIDS and Tuberculosis with Progressive Cough, Dyspnea, and Wasting Douglas Wilson, M.B., Ch.B., Roco M. Hurtado, M.D., and Subba Digumarthy, M.D. Presentation of Case Dr.

One of the challenges facing the tuberculosis control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis .